Discover 1,171 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,171
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes and Chronic Kidney Disease
for
Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic
Location: Cincinnati OH, Gaffney SC, Raleigh NC, Kansas City MO,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
Location: Cincinnati OH, Louisville KY, Indianapolis IN,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Cincinnati OH, Richmond IN, Lexington KY, Greenfield IN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & ResponsiveNew
Early Feasibility Study of the Capstan Medical TMVR System
for
Mitral Regurgitation (MR)
Location: Cincinnati OH
Sponsor: Capstan Medical
Sex: All
Age: 18+
Code: NCT07917208
Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight
Location: Cincinnati OH, Evansville IN, Chicago IL, Evanston IL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07595549
Phase 3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)